HK Opening Bell | Market Mixed at Open; Metis TechBio Skyrockets 173% on Its Debut; JD Names Rally with JD-SW up 4%, JD Logistics up 7%; Alibaba, Baidu Fall Around 1%

HK Opening Bell05-13

1. Market Overview

The Hang Seng Index edged up 0.08% to 26,369.99 at the opening bell, while the China Enterprises Index slipped 0.05% to 8,877.61. The Hang Seng Tech Index weakened 0.30% to 5,055.41, reflecting divergent early-session sentiment as investors weighed sector-specific catalysts against a broadly stable macro backdrop.

Early trading saw strength in the broader JD.com ecosystem and gold miners, contrasting with softness in mainland semiconductor names. Select consumer plays such as Pop Mart also outperformed, whereas contract research organisations and chipmakers faced profit-taking pressure.

2. Sector Performance

Large Technology Names

Baidu-SW falls 1.79%, Bilibili-W falls 1.17%, NetEase-S falls 1.08%, Alibaba-SW falls 0.98%, Lenovo falls 0.54%, Tencent falls 0.26%, Kuaishou flat 0.00%, Xiaomi rises 0.19%, Meituan rises 0.65%, JD-SW rises 3.63% (leads gains in mega-cap tech).

3. HK Top Gainers 10

Stock

Code

Price (HK$)

Gain

METIS TECHBIO-P

07666

28.68

+173.14%

PEGBIO CO-B

02565

27.08

+12.27%

JD LOGISTICS

02618

16.03

+7.01%

GENSCRIPT BIO

01548

15.29

+5.45%

MMG

01208

10.55

+4.25%

JD INDUSTRIALS

07618

15.00

+4.17%

CHINAGOLDINTL

02099

180.90

+3.97%

POP MART

09992

169.20

+3.87%

JD-SW

09618

122.70

+3.63%

JD HEALTH

06618

47.00

+3.43%

Filter: Market cap above HK$10 billion

4. HK Top Losers 10

Stock

Code

Price (HK$)

Loss

TIGERMED

03347

35.52

-6.58%

ILUVATAR COREX

09903

501.00

-3.65%

CHINA STAR ENT

00326

7.05

-3.42%

SMIC

00981

74.35

-2.94%

GIGADEVICE

03986

490.80

-2.81%

HUAQIN

03296

105.00

-2.78%

XUANZHUBIO-B

02575

21.40

-2.73%

CSOP Samsung Electronics Daily (2x) Leveraged Product

07747

136.45

-2.67%

INSILICO

03696

62.70

-2.49%

CIG

06166

136.80

-2.36%

Filter: Market cap above HK$10 billion

5. Opening Summary

The Hong Kong market kicked off Wednesday on a cautious note, with the Hang Seng Index hovering just above the flatline and the HSCEI slipping marginally. The tech-heavy HSTECH lagged, signalling selective profit-taking after recent gains, while overall sentiment remained balanced.

Large-cap internet names delivered a mixed picture. JD-related counters defied the softer Tech Index: JD Logistics surged more than 7% on continued cost-cut optimism, with JD-SW and JD Health both rising over 3%. Conversely, Baidu, NetEase and Bilibili retreated, and Tencent eased modestly.

The biggest individual gainer was newly-listed Metis TechBio, skyrocketing more than 170% on its debut, though the move had little read-through for the wider market. On the downside, CRO heavyweight Tigermed fell nearly 7%, extending weakness seen across the biotech services space. Chipmakers SMIC and Hua Hong Semi also weighed as investors locked in recent semiconductor gains.

Early sector flow favoured gold miners and base-metal names such as China Gold International and MMG amid firmer bullion prices. With no major macro headlines released during the morning, traders are watching mainland data due later in the week and U.S. inflation figures for broader direction, while primary-market activity stays brisk following Metis TechBio’s strong start.

Source: Public market data and media reports

Disclaimer: For reference only. Not investment advice.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment